Perspective Therapeutics, Inc. (CATX)
2.62
+0.11
(+4.38%)
USD |
NYAM |
Jan 14, 16:00
2.56
-0.06
(-2.29%)
Pre-Market: 09:18
Perspective Therapeutics SG&A Expense (TTM): 31.53M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Outset Medical, Inc. | 92.14M |
| InfuSystem Holdings, Inc. | 66.30M |
| Xtant Medical Holdings, Inc. | 74.03M |
| VolitionRX Ltd. | 13.97M |
| Catheter Precision, Inc. | 12.42M |